Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Drug-drug Interaction Study of UIC202601 and UIC202602 in Healthy Volunteers
NCT07682948Phase 1Recruiting
- Sponsor
- Korea United Pharm Inc.
- Start
- Jul 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Korea United Pharm Inc. Primary endpoints: Area Under the Curve at Steady State and Maximum Plasma Concentration at Steady State. Started Jul 2026; status: recruiting.
02
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT07682948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682948.